Rituximab cuts autoantibodies to insulin in study

08/18/2011 | HealthDay News

Rituximab treatment worked better than a placebo in suppressing autoantibodies to insulin in patients with new-onset type 1 diabetes, a study in Diabetes found. About 40% of rituximab-treated patients had no IAAs after a year, while no patient on the placebo had the same result, researchers said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Claims Director
PacificSource
Springfield, OR
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA